Cargando…
Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients
Solid organ transplant (SOT) recipients receive therapeutic immunosuppression that compromises their immune response to infections and vaccines. For this reason, SOT patients have a high risk of developing severe coronavirus disease 2019 (COVID-19) and an increased risk of death from severe acute re...
Autores principales: | Peter, Lena, Wendering, Désirée Jacqueline, Schlickeiser, Stephan, Hoffmann, Henrike, Noster, Rebecca, Wagner, Dimitrios Laurin, Zarrinrad, Ghazaleh, Münch, Sandra, Picht, Samira, Schulenberg, Sarah, Moradian, Hanieh, Mashreghi, Mir-Farzin, Klein, Oliver, Gossen, Manfred, Roch, Toralf, Babel, Nina, Reinke, Petra, Volk, Hans-Dieter, Amini, Leila, Schmueck-Henneresse, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882037/ https://www.ncbi.nlm.nih.gov/pubmed/35252469 http://dx.doi.org/10.1016/j.omtm.2022.02.012 |
Ejemplares similares
-
CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant Recipients
por: Amini, Leila, et al.
Publicado: (2021) -
The Value of a Rapid Test of Human Regulatory T Cell Function Needs to be Revised
por: Wendering, Desiree J., et al.
Publicado: (2019) -
Strong Expansion of Human Regulatory T Cells for Adoptive Cell Therapy Results in Epigenetic Changes Which May Impact Their Survival and Function
por: Ou, Kristy, et al.
Publicado: (2021) -
mRNA Transfection-Induced Activation of Primary Human Monocytes and Macrophages: Dependence on Carrier System and Nucleotide Modification
por: Moradian, Hanieh, et al.
Publicado: (2020) -
Comprehensive Characterization of a Next-Generation Antiviral T-Cell Product and Feasibility for Application in Immunosuppressed Transplant Patients
por: Amini, Leila, et al.
Publicado: (2019)